| # | Drug | Count |
|---|---|---|
| 0 | ATEZOLIZUMAB | 38 |
| 1 | BEVACIZUMAB | 36 |
| 2 | SORAFENIB | 21 |
| 3 | DOXORUBICIN | 17 |
| 4 | CISPLATIN | 14 |
| 5 | CYCLOPHOSPHAMIDE | 12 |
| 6 | CYCLOPHOSPHAMIDE FOR INJECTION | 12 |
| 7 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 12 |
| 8 | NIVOLUMAB | 12 |
| 9 | PEMBROLIZUMAB | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ETHIODIZED OIL | 5 | 0.0039 |
| 1 | TRASTUZUMAB-QYYP | 1 | 0.0026 |
| 2 | BEVACIZUMAB-BVZR | 1 | 0.0015 |
| 3 | BISACODYL 5MG | 1 | 0.0011 |
| 4 | PENICILLAMINE | 1 | 0.0011 |
| 5 | SORAFENIB | 21 | 0.0010 |
| 6 | ATEZOLIZUMAB | 38 | 0.0010 |
| 7 | PENTOSTATIN | 1 | 0.0010 |
| 8 | ZIV-AFLIBERCEPT | 1 | 0.0008 |
| 9 | DACARBAZINE | 4 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 61 | 0.0003 |
| 1 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 38 | 0.0002 |
| 2 | Radiographic Contrast Agent [EPC] | 5 | 0.0002 |
| 3 | Somatostatin Analog [EPC] | 1 | 0.0001 |
| 4 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 6 | 0.0001 |
| 5 | Glinide [EPC] | 1 | 0.0001 |
| 6 | Cannabinoid [EPC] | 1 | 0.0001 |
| 7 | CTLA-4-directed Blocking Antibody [EPC] | 4 | 0.0001 |
| 8 | Platinum-based Drug [EPC] | 22 | 0.0001 |
| 9 | Kinase Inhibitor [EPC] | 37 | 0.0001 |